Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia (Q46738245)
Jump to navigation
Jump to search
scientific article published on 19 February 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia |
scientific article published on 19 February 2008 |
Statements
1 reference
Phase I study of dexamethasone, methotrexate, ifosfamide, L-asparaginase, and etoposide (SMILE) chemotherapy for advanced-stage, relapsed or refractory extranodal natural killer (NK)/T-cell lymphoma and leukemia (English)
1 reference
Motoko Yamaguchi
1 reference
Ritsuro Suzuki
1 reference
Yok-Lam Kwong
1 reference
Won Seog Kim
1 reference
Yuichi Hasegawa
1 reference
Koji Izutsu
1 reference
Junji Suzumiya
1 reference
Takayuki Okamura
1 reference
Shigeo Nakamura
1 reference
Keisei Kawa
1 reference
Kazuo Oshimi
1 reference
19 February 2008
1 reference
1 reference
99
1 reference
5
1 reference
1016-1020
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference